TickerFactsScreenerDevelopers

BioNexus Gene Lab Corp (BGLC) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2018: -$274.1K2019: -$217.3K2020: $552.7K2021: $9.2K2022: $551.8K2023: -$1.82M2024: -$2.09M2025: -$1.84M-$1.84M
2018Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$1.84M+12.2%
2024-$2.09M-14.9%
2023-$1.82M-430.2%
2022$551.8K+5923.6%
2021$9.2K-98.3%
2020$552.7K+354.4%
2019-$217.3K+20.7%
2018-$274.1K—